Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Generic compound preparation BNF 1202030
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Bismuth subnit 20% /Iodo 40% paste IG dressing 2.5cm x 100cm
120203000AAAEAE
|
Generic compound preparation BNF 1202030 | Other nasal infection preparations | Ear, Nose and Oropharynx | No data available |
|
Bismuth subnit 20% /Iodo 40% paste IG dressing 2.5cm x 200cm
120203000AAAFAF
|
Generic compound preparation BNF 1202030 | Other nasal infection preparations | Ear, Nose and Oropharynx | No data available |
|
Bismuth subnit 20% /Iodo 40% paste IG dressing 2.5cm x 300cm
120203000AAAGAG
|
Generic compound preparation BNF 1202030 | Other nasal infection preparations | Ear, Nose and Oropharynx | No data available |
|
Bismuth subnit 20%/Iodo 40% paste IG dressing 1.25cm x 100cm
120203000AAABAB
|
Generic compound preparation BNF 1202030 | Other nasal infection preparations | Ear, Nose and Oropharynx | No data available |
|
Bismuth subnit 20%/Iodo 40% paste IG dressing 1.25cm x 200cm
120203000AAACAC
|
Generic compound preparation BNF 1202030 | Other nasal infection preparations | Ear, Nose and Oropharynx | No data available |
|
Bismuth subnit 20%/Iodo 40% paste IG dressing 1.25cm x 300cm
120203000AAADAD
|
Generic compound preparation BNF 1202030 | Other nasal infection preparations | Ear, Nose and Oropharynx | No data available |
|
Bismuth subnitrate and Iodoform paste 30g sachets
120203000AAAAAA
|
Generic compound preparation BNF 1202030 | Other nasal infection preparations | Ear, Nose and Oropharynx | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.